De La Salle H - Search Results

1

A novel mutation for TAP deficiency and its possible association with Toxoplasmosis.

Doğu F, Ikincioğullari A, Fricker D, Bozdoğan G, Aytekin C, Ileri M, Teziç T, Babacan E, De La Salle H. Doğu F, et al. Among authors: de la salle h. Parasitol Int. 2006 Sep;55(3):219-22. doi: 10.1016/j.parint.2006.02.003. Epub 2006 Apr 19. Parasitol Int. 2006. PMID: 16624613

2

Novel human pathological mutations. Gene symbol: TAP2. Disease: HLA class I deficiency.

de la Salle H, Fricker D, Hanau D, Dogu F, Ikinciogullari A. de la Salle H, et al. Hum Genet. 2007 Jun;121(5):646-7. Hum Genet. 2007. PMID: 17879436 No abstract available.

3

HLA class I deficiency syndrome mimicking Wegener's granulomatosis.

Villa-Forte A, de la Salle H, Fricker D, Hentges F, Zimmer J. Villa-Forte A, et al. Among authors: de la salle h. Arthritis Rheum. 2008 Aug;58(8):2579-82. doi: 10.1002/art.23675. Arthritis Rheum. 2008. PMID: 18668571 Free article.

4

Novel human pathological mutations. Gene symbol: TAP2. Disease: HLA class I deficiency.

de la Salle H, Fricker D, Hanau D, Langguth D, Hogan P. de la Salle H, et al. Hum Genet. 2007 Jun;121(5):651. Hum Genet. 2007. PMID: 17879452 No abstract available.

5

Homozygous human TAP peptide transporter mutation in HLA class I deficiency.

de la Salle H, Hanau D, Fricker D, Urlacher A, Kelly A, Salamero J, Powis SH, Donato L, Bausinger H, Laforet M, et al. de la Salle H, et al. Science. 1994 Jul 8;265(5169):237-41. doi: 10.1126/science.7517574. Science. 1994. PMID: 7517574

6

Asymptomatic deficiency in the peptide transporter associated to antigen processing (TAP).

de la Salle H, Saulquin X, Mansour I, Klayme S, Fricker D, Zimmer J, Cazenave JP, Hanau D, Bonneville M, Houssaint E, Lefranc G, Naman R. de la Salle H, et al. Clin Exp Immunol. 2002 Jun;128(3):525-31. doi: 10.1046/j.1365-2249.2002.01862.x. Clin Exp Immunol. 2002. PMID: 12067308 Free PMC article.

7

HLA class I deficiencies due to mutations in subunit 1 of the peptide transporter TAP1.

de la Salle H, Zimmer J, Fricker D, Angenieux C, Cazenave JP, Okubo M, Maeda H, Plebani A, Tongio MM, Dormoy A, Hanau D. de la Salle H, et al. J Clin Invest. 1999 Mar;103(5):R9-R13. doi: 10.1172/JCI5687. J Clin Invest. 1999. PMID: 10074495 Free PMC article.

8

Human peptide transporter deficiency: importance of HLA-B in the presentation of TAP-independent EBV antigens.

de la Salle H, Houssaint E, Peyrat MA, Arnold D, Salamero J, Pinczon D, Stevanovic S, Bausinger H, Fricker D, Gomard E, Biddison W, Lehner P, UytdeHaag F, Sasportes M, Donato L, Rammensee HG, Cazenave JP, Hanau D, Tongio MM, Bonneville M. de la Salle H, et al. J Immunol. 1997 May 15;158(10):4555-63. J Immunol. 1997. PMID: 9144467

9

Unilateral necrotising toxoplasmic retinochoroiditis as the main clinical manifestation of a peptide transporter (TAP) deficiency.

Parissiadis A, Dormoy A, Fricker D, Hanau D, de la Salle H, Cazenave JP, Lenoble P, Donato L. Parissiadis A, et al. Among authors: de la salle h. Br J Ophthalmol. 2005 Dec;89(12):1661-2. doi: 10.1136/bjo.2005.078097. Br J Ophthalmol. 2005. PMID: 16299152 Free PMC article. No abstract available.

10

CD1 expression is not affected by human peptide transporter deficiency.

Hanau D, Fricker D, Bieber T, Esposito-Farese ME, Bausinger H, Cazenave JP, Donato L, Tongio MM, de la Salle H. Hanau D, et al. Among authors: de la salle h. Hum Immunol. 1994 Sep;41(1):61-8. doi: 10.1016/0198-8859(94)90086-8. Hum Immunol. 1994. PMID: 7530699

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

107 results

Search Page

Filters